Gal Akiri
Technion – Israel Institute of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gal Akiri.
Cancer Research | 2008
Asya Varshavsky; Ofra Kessler; Sivan Abramovitch; Boaz Kigel; Shelly Zaffryar; Gal Akiri; Gera Neufeld
Semaphorin-3B (sema3B) and semaphorin-3F (sema3F) are secreted tumor suppressors of lung cancer. Sema3F functions as an antiangiogenic factor that repels endothelial cells and compromises their proliferation/survival. However, tumor cells expressing either endogenous or recombinant sema3B fail to repel endothelial cells efficiently. Sema3B found in the conditioned medium of such cells is almost completely cleaved by furin-like pro-protein convertases, generating inactive 61- and 22-kDa fragments. We have generated a sema3B variant that was point mutated at the cleavage site (sema3B-m), thereby conferring partial resistance to cleavage. Conditioned medium from HEK293 cells expressing sema3b-m and conditioned medium of HEK293 cells expressing sema3B contained similar concentrations of semaphorin but sema3B-m was cleaved much less than sema3B. In contrast to HEK293 cells expressing native sema3B, cells expressing sema3b-m strongly repel endothelial cells. Conditioned medium from sema3B-m-expressing cells rapidly caused disassembly of focal adhesions and a collapse of the actin cytoskeleton of endothelial cells, inhibited vascular endothelial growth factor-induced phosphorylation of extracellular signal-regulated kinase 1/2, induced apoptosis of endothelial cells, and inhibited the formation of tubes from endothelial cells in an in vitro angiogenesis assay more potently than conditioned medium from cells expressing sema3B. Furthermore, HEK293 cells expressing sema3B-m inhibited basic fibroblast growth factor-induced angiogenesis in vivo much more potently than cells expressing sema3B. Repulsion of human umbilical vascular endothelial cells by sema3B-m was mediated primarily by the neuropilin-1 (np1) receptor but sema3B-m was also able to transduce signals via neuropilin-2 (np2). These results suggest that up-regulation of furin-like pro-protein convertases in malignant cells may enable tumors to evade the antiangiogenic effects of sema3B.
Developmental Cell | 2016
Ortal Kraft-Sheleg; Shelly Zaffryar-Eilot; Olga Genin; Wesal Yaseen; Sharon Soueid-Baumgarten; Ofra Kessler; Tatyana Smolkin; Gal Akiri; Gera Neufeld; Yuval Cinnamon; Peleg Hasson
For muscles to function, myofibers have to stretch and anchor at the myotendinous junction (MTJ), a region rich in extracellular matrix (ECM). Integrin signaling is required for MTJ formation, and mutations affecting the cascade lead to muscular dystrophies in mice and humans. Underlying mechanisms for integrin activation at the MTJ and ECM modifications regulating its signaling are unclear. We show that lysyl oxidase-like 3 (LoxL3) is a key regulator of integrin signaling that ensures localized control of the cascade. In LoxL3 mutants, myofibers anchor prematurely or overshoot to adjacent somites, and are loose and lack tension. We find that LoxL3 complexes with and directly oxidizes Fibronectin (FN), an ECM scaffold protein and integrin ligand enriched at the MTJ. We identify a mechanism whereby localized LoxL3 secretion from myofiber termini oxidizes FN, enabling enhanced integrin activation at the tips of myofibers and ensuring correct positioning and anchoring of myofibers along the MTJ.
Cancer Research | 2003
Gal Akiri; Edmond Sabo; Hagit Dafni; Zehava Vadasz; Yelena Kartvelishvily; Noga Gan; Ofra Kessler; Tzafra Cohen; Murray B. Resnick; Michal Neeman; Gera Neufeld
Journal of Hepatology | 2005
Zehava Vadasz; Ofra Kessler; Gal Akiri; Stela Gengrinovitch; Herbert M. Kagan; Yaacov Baruch; Ofer Ben Izhak; Gera Neufeld
Archive | 2009
Gera Neufeld; Gal Akiri; Zahava Vadasz; Stela Gengrinovitch
Archive | 2002
Gera Neufeld; Gal Akiri; Zahava Vadasz; Stela Gengrinovitch
Archive | 2003
Gera Neufeld; Gal Akiri; Zahava Vadasz; Stela Gengrinovitch
Archive | 2001
Gera Neufeld; Gal Akiri; Zahava Vadasz; Stela Gengrovitch
Archive | 2003
Gera Neufeld; Gal Akiri; Zahava Vadasz; Stela Gengrinovitch
Archive | 2001
Gal Akiri; Stela Gengrovitch; Gera Neufeld; Zahava Vadasz